A MAP4K4-blocking drug could be ready to test in people who have had heart attacks by 2022. (takasuu/iStock/Getty Imag...

Autoimmune diseases, including type 1 diabetes and multiple sclerosis, arise when the body's immune cells attack itself. Current treatments eliminate these misfunctio...

Celastrol's potent anti-obesity effects were widely reported in 2015. Derived from the roots of the thunder god vine, the drug curbed food intake in obese mice by nea...

Following the news on 4th March 2019 that US-based biotechnology company, Biogen, has agreed to acquire London-based clinical-stage gene therapy company, Nightstar Th...

Stevenage, UK, 5th March 2019 / Sciad Newswire / Procarta Biosystems, a privately held UK-based biotech company, today announced €1.5m of new funding from the Novo Ho...

GOETTINGEN, Germany, March 05, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading supplier for the biopharmaceutical industry, and Novasep based in Po...

Leading stem cell research group and global leader in organ-on-a-chip technology develop stem cell-derived kidney tubules in microfluidic chips. LEIDEN, the Netherla...

Following the recent news that Biogen’s Spinraza (nusinersen) won approval from China’s National Medical Products Association (NMPA) as a treatment for spinal muscula...

Continued Collaboration Facilitates Global Distribution of Obesity, Metabolic Disease, and NASH Model and Priority Supply to CrownBio’s World-Class Cardiovascular, Ob...

AbbVie and Eisai announced recently that Humira, a fully human anti-TNF-α monoclonal antibody, has received additional approval for the treatment of hidradenitis supp...